Fundz

Watching Johnson & Johnson? See every signal: funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Back to SEC Filings
Material AgreementItem 1.01 · 8-KLOW RiskPositive

Johnson & Johnson

jnj.com
Filed: Aug 4, 2026New Brunswick, New JerseyCIK: 0000200406hospital & health care
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Johnson & Johnson issued multiple tranches of notes on August 4, 2026, ranging from 1.150% to 3.700% with maturities between 2028 and 2055, as part of a refinancing and operational funding strategy that will impact the company's capital structure and liquidity profile.

Key Takeaways

J&J completed issuance of 10 separate note tranches with interest rates ranging from 1.150% to 3.700% and maturity dates spanning from November 2028 to February 2055

The financing strategy is designed to refinance existing debt obligations and support operational initiatives while extending the company's maturity profile

1 more takeaway

Related Filings (1)

1 more filing from Johnson & Johnson in the last 90 days

Filing Overview

Form Type8-K
Filing DateAug 4, 2026
Item1.01
CategoryMaterial Agreement
CIK0000200406
Accession #jnj-20260804
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
debt financing

What This Means

The company entered into a significant agreement that could materially affect its business. This often signals new partnerships, licensing deals, or major contracts.
View Full Filing on SEC.govBrowse More Filings

Johnson & Johnson filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.